HK1247280A1 - 用於從含纖維蛋白原的樣品中分離目標分子或顆粒的方法 - Google Patents
用於從含纖維蛋白原的樣品中分離目標分子或顆粒的方法Info
- Publication number
- HK1247280A1 HK1247280A1 HK18106745.5A HK18106745A HK1247280A1 HK 1247280 A1 HK1247280 A1 HK 1247280A1 HK 18106745 A HK18106745 A HK 18106745A HK 1247280 A1 HK1247280 A1 HK 1247280A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- fibrinogen
- particles
- target molecules
- containing samples
- separating target
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/14—Streptococcus; Staphylococcus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/974—Thrombin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH14782010 | 2010-09-15 | ||
| CH20412010 | 2010-12-07 | ||
| CH12072011 | 2011-07-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1247280A1 true HK1247280A1 (zh) | 2018-09-21 |
Family
ID=45044632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18106745.5A HK1247280A1 (zh) | 2010-09-15 | 2018-05-24 | 用於從含纖維蛋白原的樣品中分離目標分子或顆粒的方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US9689881B2 (zh) |
| EP (2) | EP2616550B1 (zh) |
| JP (1) | JP5999776B2 (zh) |
| KR (1) | KR101948944B1 (zh) |
| CN (2) | CN107389932B (zh) |
| AU (2) | AU2011303467C1 (zh) |
| CA (1) | CA2811493C (zh) |
| CY (1) | CY1122166T1 (zh) |
| DK (2) | DK3067431T3 (zh) |
| ES (2) | ES2751660T3 (zh) |
| HK (1) | HK1247280A1 (zh) |
| HR (1) | HRP20191785T1 (zh) |
| HU (2) | HUE028915T2 (zh) |
| LT (1) | LT3067431T (zh) |
| PL (2) | PL2616550T3 (zh) |
| PT (1) | PT3067431T (zh) |
| SI (1) | SI3067431T1 (zh) |
| WO (1) | WO2012035508A2 (zh) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2811493C (en) | 2010-09-15 | 2020-06-16 | Spinomix S.A. | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
| CA2840568C (en) | 2011-06-27 | 2021-05-04 | Emory University | Compositions, uses, and preparation of platelet lysates |
| ES2766760T3 (es) * | 2013-03-29 | 2020-06-15 | Siemens Healthcare Diagnostics Inc | Concentración de células raras |
| WO2015186049A1 (en) | 2014-06-01 | 2015-12-10 | Debiopharm International Sa | Sample collection and processing device |
| EP3426400B1 (en) | 2016-03-10 | 2020-09-02 | Arthrex Inc | System for preparing protein enhanced serums |
| WO2017156375A1 (en) | 2016-03-10 | 2017-09-14 | Arthrex, Inc. | Systems and methods for preparing a thrombin serum |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1035260A (en) * | 1974-08-12 | 1978-07-25 | Baxter Travenol Laboratories | Collection and processing tube |
| FR2625321B1 (fr) * | 1987-12-24 | 1992-10-02 | Pasteur Institut | Reactif pour le diagnostic de staphylococcus aureus par agglutination |
| DE3803463A1 (de) * | 1988-02-05 | 1989-08-17 | Linhart Axel | Semiquantitativer kalzium-schnelltest |
| EP0325106B1 (de) * | 1988-01-05 | 1992-10-21 | Axel Dr. Linhart | Verfahren und Test-Kit zur semiquantitativen Bestimmung des Kalziumgehaltes im Blut |
| US5691160A (en) * | 1992-08-14 | 1997-11-25 | Biogen, Inc. | Effects of actin filaments of fibrin clot structure and lysis |
| DE69316293T2 (de) * | 1992-09-09 | 1998-08-27 | Tokuyama Corp | Methode zur Bestimmung von Fibrinogen, trockenes Reagens hierfür und Verfahren zur Herstellung desselben |
| JP3292760B2 (ja) * | 1993-04-22 | 2002-06-17 | テルモ株式会社 | 採血管およびその製造方法 |
| US5670329A (en) * | 1993-05-28 | 1997-09-23 | Cardiovascular Diagnostics, Inc. | Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field |
| EP0731847A1 (en) | 1993-12-03 | 1996-09-18 | Gordon L. Dorn | Method for improving quantitative recovery of microorganisms fro m specimens containing blood components |
| DE19602673A1 (de) * | 1996-01-25 | 1997-08-07 | Pereg Gmbh | Synthetische Testanschmutzung |
| US6121232A (en) * | 1997-01-31 | 2000-09-19 | Omrix Biopharmaceuticals Sa | Stabilized mixture comprising fibrinogen |
| US6680195B1 (en) * | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| JP2000262499A (ja) * | 2000-01-01 | 2000-09-26 | Terumo Corp | 採血管 |
| US6686204B2 (en) * | 2001-08-27 | 2004-02-03 | Becton, Dickinson & Company | Collection device |
| CN1606447A (zh) * | 2001-10-03 | 2005-04-13 | 克里斯托弗·J·伍尔弗顿 | 保存稳定的纤维蛋白原溶液 |
| JP4718833B2 (ja) * | 2002-05-01 | 2011-07-06 | シナプス ベスローテン フェンノートシャップ | 複合生物媒体における、一時的なタンパク質分解活性の濃度を決定するための診断試験 |
| ATE335816T1 (de) | 2002-09-18 | 2006-09-15 | Sirs Lab Gmbh | Verfahren zum nachweis prokaryontischer dna |
| SI1654387T1 (sl) * | 2003-08-15 | 2009-10-31 | Univ South Florida | Materiali in postopki za ujetje patogenov in odstranitev avrintrikarboksilne kisline iz vzorca |
| US20050065454A1 (en) * | 2003-09-22 | 2005-03-24 | Becton, Dickinson And Company | Non-evacuated blood collection tube |
| US7399609B2 (en) * | 2003-12-30 | 2008-07-15 | 3M Innovative Properties Company | Staphylococcus detection |
| US8419722B2 (en) * | 2004-10-29 | 2013-04-16 | Spinal Restoration, Inc. | Apparatus and method for injection of fibrin sealant in spinal applications |
| DE102005009479A1 (de) | 2005-03-02 | 2006-09-07 | Molzym Gmbh & Co. Kg | Verwendung von Nukleasen zum Abbau von Nukleinsäure in Gegenwart von chaotropen Agenzien und/oder Tensiden |
| US20100009409A1 (en) * | 2005-07-29 | 2010-01-14 | Ecole Polytechnique Federale De Lausanne | Molecular variant fibrinogen fusion proteins |
| ES2387700T3 (es) * | 2007-05-03 | 2012-09-28 | Accumetrics, Inc. | Métodos para medir la inhibición de la agregación de plaquetas mediante antagonistas del receptor de trombina |
| CA2693565C (en) | 2007-08-02 | 2015-05-26 | Universite Laval | Concentration and enrichment of microbial cells and microbial nucleic acids from bodily fluids |
| JP5029217B2 (ja) * | 2007-08-27 | 2012-09-19 | 東レ株式会社 | シート状物の製造方法 |
| AU2009268052B2 (en) * | 2008-07-09 | 2015-05-28 | Mallinckrodt Pharma Ip Trading D.A.C. | Recombinant fibrinogen |
| EP2453915B1 (en) | 2009-07-16 | 2017-04-19 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin | Treatment of infections |
| CA2811493C (en) | 2010-09-15 | 2020-06-16 | Spinomix S.A. | Method for separating target molecules or particles from fibrinogen-containing samples including blood components |
-
2011
- 2011-09-15 CA CA2811493A patent/CA2811493C/en active Active
- 2011-09-15 ES ES16154770T patent/ES2751660T3/es active Active
- 2011-09-15 EP EP11788227.4A patent/EP2616550B1/en active Active
- 2011-09-15 SI SI201131797T patent/SI3067431T1/sl unknown
- 2011-09-15 PL PL11788227T patent/PL2616550T3/pl unknown
- 2011-09-15 CN CN201710338814.XA patent/CN107389932B/zh active Active
- 2011-09-15 JP JP2013528815A patent/JP5999776B2/ja active Active
- 2011-09-15 PT PT161547708T patent/PT3067431T/pt unknown
- 2011-09-15 KR KR1020137009329A patent/KR101948944B1/ko active IP Right Grant
- 2011-09-15 HU HUE11788227A patent/HUE028915T2/en unknown
- 2011-09-15 US US13/822,209 patent/US9689881B2/en active Active
- 2011-09-15 DK DK16154770.8T patent/DK3067431T3/da active
- 2011-09-15 WO PCT/IB2011/054035 patent/WO2012035508A2/en active Application Filing
- 2011-09-15 HU HUE16154770A patent/HUE045771T2/hu unknown
- 2011-09-15 DK DK11788227.4T patent/DK2616550T3/en active
- 2011-09-15 CN CN201180044211.XA patent/CN103108959B/zh active Active
- 2011-09-15 ES ES11788227T patent/ES2571127T3/es active Active
- 2011-09-15 PL PL16154770T patent/PL3067431T3/pl unknown
- 2011-09-15 LT LT16154770T patent/LT3067431T/lt unknown
- 2011-09-15 EP EP16154770.8A patent/EP3067431B1/en active Active
- 2011-09-15 AU AU2011303467A patent/AU2011303467C1/en active Active
-
2016
- 2016-12-02 AU AU2016266066A patent/AU2016266066B2/en active Active
-
2017
- 2017-05-22 US US15/601,677 patent/US20170336424A1/en not_active Abandoned
-
2018
- 2018-05-24 HK HK18106745.5A patent/HK1247280A1/zh unknown
-
2019
- 2019-10-02 HR HRP20191785TT patent/HRP20191785T1/hr unknown
- 2019-10-11 CY CY20191101074T patent/CY1122166T1/el unknown
-
2021
- 2021-01-28 US US17/160,814 patent/US20210148940A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1249475A1 (zh) | 基於微陣列的樣檢系統 | |
| HK1247280A1 (zh) | 用於從含纖維蛋白原的樣品中分離目標分子或顆粒的方法 | |
| HK1243375A1 (zh) | 樣本分析系統 | |
| EP2462157A4 (en) | PROCESS FOR CLEANING A TARGET PROTEIN OF ONE OR MORE CONTAMINANTS IN A SAMPLE | |
| EP2588947A4 (en) | METHOD AND APPARATUS FOR TARGET INTERACTION AND PREDICTION BASED ON MOVEMENT | |
| EP2699693A4 (en) | METHODS FOR ISOLATING A TARGET ANALYTE FROM A HETEROGENEOUS SAMPLE | |
| EP2723904A4 (en) | METHOD AND COMPOSITIONS FOR SEPARATING A TARGET NUCLEIC ACID OF MIXED NUCLEIC ACID SAMPLES | |
| GB201111357D0 (en) | Method and apparatus for identification of samples field of the invention | |
| SG11201406727QA (en) | Apparatus and method for separating a biological entity from a sample volume | |
| GB201407289D0 (en) | Methods and compositions for sample identification | |
| EP2524234A4 (en) | SAMPLE ANALYSIS APPARATUS | |
| HK1180345A1 (zh) | 篩選抗體的方法 | |
| EP2844373A4 (en) | METHOD FOR ANALYZING SAMPLE COMPONENTS | |
| EP2840381A4 (en) | METHOD FOR DETECTION OF TARGET PARTICLES | |
| GB2480136B (en) | Method for the mass spectrometric detection of bacteria | |
| EP2924005A4 (en) | PROCESS FOR OBTAINING SUSPENSIONS OR SOLID GRAPHENE SAMPLE | |
| EP2752655A4 (en) | PROCEDURE FOR DETECTING TARGET PARTICLES | |
| IL224318B (en) | A method for the automated synthesis of small molecules | |
| EP2711421A4 (en) | METHOD OF SEPARATING AND PURIFYING RNA FROM BIOLOGICAL MATERIAL | |
| EP2544799A4 (en) | SYSTEM AND METHOD FOR SEPARATING SOLIDS FROM LIQUIDS | |
| EP2913660A4 (en) | METHOD OF DETECTING TARGET PARTICLES | |
| HK1197269A1 (zh) | 篩選具有控制體重作用的物質的方法 | |
| EP2545244A4 (en) | SYSTEM AND METHOD FOR SEPARATING SOLIDS FROM LIQUIDS | |
| EP2841533B8 (en) | Processing unit and method for separating hydrocarbons from feedstock material | |
| EP2725347A4 (en) | METHOD FOR DETECTING TARGET PARTICLES |